Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Conditions:   Pituitary;   Pituitary Tumor;   Pituitary Carcinoma;   Pituitary Cancer Interventions:   Drug: Ipilimumab;   Drug: Nivolumab Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials